Fabrinet (FN) PT Raised to $135 at Needham & Company Following 'Solid' EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
After-Hours Movers: Ginkgo Bioworks, Fabrinet Gain Post Earnings; ZipRecruiter Drops
August 15, 2022 6:00 PM EDTAfter-Hours Stock Movers:
Ginkgo Bioworks (NYSE: DNA) 23% HIGHER; reported Q2 EPS of ($0.41), $0.36 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $145 million versus the consensus estimate of $78.83 million. Ginkgo Bioworks sees FY2022... More
Fabrinet Shares Surge 13% on Q4 Beat & Better Than Expected Guidance
August 15, 2022 5:15 PM EDTFabrinet (NYSE: FN) shares soar nearly 13% after-hours following the companys reported Q4 results, with EPS of $1.68 coming in better than the consensus estimate of $1.54. Revenue was $587.9 million, beating the consensus estimate of $581.48 million.
With strong ongoing demand trends, we are optimistic... More
Fabrinet (FN) Tops Q4 EPS by 14c
August 15, 2022 4:22 PM EDTFabrinet (NYSE: FN) reported Q4 EPS of $1.68, $0.14 better than the analyst estimate of $1.54. Revenue for the quarter came in at $587.9 million versus the consensus estimate of $581.48 million.
GUIDANCE:
Fabrinet sees Q1 2023 EPS of $1.72-$1.79, versus the consensus of $1.56. Fabrinet sees Q1... More
